Reed Smith represents Grace Therapeutics in signing of a merger agreement with Acasti Pharma
HomeNewsReed Smith represents Grace Therapeutics in signing of a merger agreement with Acasti Pharma
NEW YORK – Global law firm Reed Smith today announced that it advised Grace Therapeutics, Inc., a privately held biopharmaceutical company focused on developing drug treatment technologies of rare and orphan diseases, on its merger with Acasti Pharma Inc. (Nasdaq: ACST and TSX-V: ACST), a biopharmaceutical company historically focused on the development and commercialization of prescription drugs using Omega-3 fatty acids.
The Reed Smith team was comprised of partners Jennifer Cheng and Niket Rele, counsel Sue Nieto, and associates Doug Sayranian and Sheran Sharafi.
A copy of the press release issued by Acasti Pharma can be found at globenewswire.com.
About Reed Smith
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. With an inclusive culture and innovative mindset, we deliver smarter, more creative legal services that drive better outcomes for our clients. Our deep industry knowledge, long-standing relationships and collaborative structure make us the go-to partner for complex disputes, transactions, and regulatory matters.